The Western blot results show that the iron chelators DFO and DFX promoted caspase-3 activation and significantly increased the levels of C-PARP and Bax and decreased the levels of Bcl-2 and PARP in osteosarcoma cells (Figure 5A,B). The gene discussed is BAX; the disease is osteosarcoma.